The New Enrollment Post-Approval Study is designed to evaluate the safety and efficacy of the Esteem Totally Implantable Hearing System in subjects suffering from moderate to severe hearing loss.
Purpose: To evaluate the long-term safety and efficacy of the Esteem Totally Implantable Hearing System (hereafter called Esteem) in subjects suffering from moderate to severe hearing loss. Questions: The following questions are to be answered: * Is Esteem effective through 1 year follow-up? * Is Esteem safe through 1 year follow-up? * Is the incidence of facial paresis/paralysis at 1 month follow-up no greater than 7%?
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
117
Subjects meeting indications are implanted with the Esteem Totally Implantable Hearing System
North Alabama ENT Associates
Madison, Alabama, United States
Pacific Hearing Service
Los Altos, California, United States
Ear, Nose, & Throat Associates of South Florida
Jupiter, Florida, United States
Ear Consultants of Georgia
Atlanta, Georgia, United States
Change in Speech Reception Threshold (SRT)
Comparison of the speech reception threshold (SRT) using the Esteem System as compared to the pre-implant aided condition. The SRT is related to hearing sensitivity; lower numbers indicate better outcomes. Here, the difference in dB is reported; positive scores indicate improvement (lower SRT) with the Esteem relative to the pre-implant hearing aid. There are no specific minimum or maximum scores for this measure.
Time frame: Change in SRT from Baseline Aided to 10-month post-activation with Esteem
Change in Word Recognition Score (WRS)
Comparison of the word recognition score using the Esteem compared to the pre-implant aided condition. For WRS, a higher score indicates a better outcome. Here, the difference in % correct is reported; positive scores indicate better performance with the Esteem relative to the pre-implant hearing aid. Scores on this test range from 0 to 100%.
Time frame: Change in WRS from Baseline Aided to 10-month post-activation with Esteem
Incidence of SADEs, Device Failures, & Replacements
The analysis of the incidence of Serious Adverse Device Effects (SADEs) and device failures and replacements
Time frame: Incidence at 10-month post-activation
Incidence of Facial Pareses/Paralysis
The analysis of the incidence of facial pareses/paralysis at one month follow-up
Time frame: Incidence at one month post-op
Change in Bone Conduction Threshold (BCT) at 500 Hz
Comparison of bone conduction (BC) threshold at 500 Hz post activation compared to the pre-implant BC threshold. Change in Bone Conduction is used to determine whether residual cochlear function has declined following implant of the Esteem. Positive numbers indicate higher (i.e., poorer) bone conduction thresholds post-implant, relative to pre-implant.
Time frame: Change in BCT from Baseline to 10-month post-activation
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Loyola Center for Hearing
Woodridge, Illinois, United States
Oklahoma Otolaryngology Associates
Norman, Oklahoma, United States
Change in Bone Conduction Threshold (BCT) at 1000 Hz
Change in BCT from Baseline to 10-month post-activation. Change in Bone Conduction is used to determine whether residual cochlear function has declined following implant of the Esteem. Positive numbers indicate higher (i.e., poorer) bone conduction thresholds post-implant, relative to pre-implant.
Time frame: Change in BCT from Baseline to 10-month post-activation
Change in Bone Conduction Threshold (BCT) at 2000 Hz
Change in BCT from Baseline to 10-month post-activation. Change in Bone Conduction is used to determine whether residual cochlear function has declined following implant of the Esteem. Positive numbers indicate higher (i.e., poorer) bone conduction thresholds post-implant, relative to pre-implant.
Time frame: Change in BCT from Baseline to 10-month post-activation
Change in Bone Conduction Threshold (BCT) at 4000 Hz
Change in BCT from Baseline to 10-month post-activation. Change in Bone Conduction is used to determine whether residual cochlear function has declined following implant of the Esteem. Positive numbers indicate higher (i.e., poorer) bone conduction thresholds post-implant, relative to pre-implant.
Time frame: Change in BCT from Baseline to 10-month post-activation
Change in Subjective Quality of Life as Measured With the Abbreviated Profile of Hearing Aid Benefit, or APHAB (Global Score)
Quality of Life measured with the APHAB comparison between the pre-implant aided condition and 10-month post-activation. In general, a lower score indicates better performance. The range of scores for each subscale (including the Global score, reported here) is 1 to 99. Here, mean difference in benefit score with the Esteem implant vs. pre-implant aided condition is reported. A positive difference score indicates more benefit with the Esteem.
Time frame: Change from Baseline Aided to 10-month post-activation with Esteem
Esteem Questionnaire Results
To gather subject feedback and comments on the use of the Esteem System through subject ratings on questionnaire items specifically focusing on factors such as the clarity of sound, the user's ability to understand speech in background noise, naturalness of sound, benefits of the system, etc. -- relative to the pre-implant aided condition. Subjects rated each item as "Is much worse", "Somewhat worse", "Is about the same", "Is somewhat better", or "Is much better" with the Esteem. Reported here are the cumulative number of respondents indicating "Same", "Somewhat better", or "Much better" for the given question.
Time frame: 10-month post-activation with Esteem